首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组人粒细胞集落刺激因子(rhG-CSF)的安全性与临床评价
引用本文:李静,陶维良,魏世东,孙劲文,张藜莉.重组人粒细胞集落刺激因子(rhG-CSF)的安全性与临床评价[J].中国医院用药评价与分析,2008,8(7):484-486.
作者姓名:李静  陶维良  魏世东  孙劲文  张藜莉
作者单位:煤炭总医院,北京市,100028
摘    要:目的:评价重组人粒细胞集落刺激因子在临床应用的作用机制、药代动力学、适应证、用法、用量及其禁忌证。方法:采用国内外文献综述方法。结果及结论:rhG-CSF在治疗粒细胞减少症、严重感染等方面有良好的前景,但选择适应证、个体化用药很重要。

关 键 词:重组人粒细胞集落刺激因子  粒细胞减少症  安全评价  不良反应

Safety and Clinical Evaluation of Recombinant Human Granulocyte Colony - stimulating Factor
LI Jing,TAO Wei-liang,WEI Shi-dong,SUN Jin-wen,ZHANG Li-li.Safety and Clinical Evaluation of Recombinant Human Granulocyte Colony - stimulating Factor[J].Evaluation and Analysis of Drug-Use in Hospital of China,2008,8(7):484-486.
Authors:LI Jing  TAO Wei-liang  WEI Shi-dong  SUN Jin-wen  ZHANG Li-li
Institution:(The Coal General Hospital, Beijing 100028, China)
Abstract:OBJECTIVE: To evaluate the action mechanism, pharmacokinetics, indications, administration and dosage, and contraindication in the clinical application of rhG - CSF. METHODS: The pertinent literature both at home and abroad was reviewed. RESULTS & CONCLUSION: The prospect for rhG - CSF to treat Granulocytopenia and severe infection etc is bright, but great importance should be attached its indications and personalized medication safety.
Keywords:Recombinate human granulocyte - colong stimulating factor  Granulocytopenia  Safety evaluation  Adverse drug reaction
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号